Menu Search
Equities

Centerra Gold Inc

CGAU:NYQ

Centerra Gold Inc

Actions
Basic MaterialsPrecious Metals and Mining
  • Price (USD)6.46
  • Today's Change-0.04 / -0.62%
  • Shares traded812.10k
  • 1 Year change+12.94%
  • Beta--
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Centerra Gold Inc. is a Canada-based gold mining company focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkiye, and other markets worldwide. The Company operates two mines: the Mount Milligan Mine in British Columbia, Canada, and the Oksut Mine in Turkiye. The Company also owns the Goldfield District Project in Nevada, United States; the Kemess Project in British Columbia, Canada, and owns and operates the Molybdenum Business Unit in the United States and Canada. The Mount Milligan Mine is an open pit mine located in north central British Columbia, Canada producing a gold and copper concentrate. The Oksut Mine is located in Turkiye approximately 300 kilometers southeast of Ankara and 48 kilometers south of Kayseri, the provincial capital. The Molybdenum BU includes the Langeloth Facility in Pennsylvania and two North American molybdenum mines: the Thompson Creek Mine in Idaho and the 75%-owned Endako Mine in British Columbia.

  • Revenue in CAD (TTM)1.74bn
  • Net income in CAD144.82m
  • Incorporated2002
  • Employees1.24k
  • Location
    Centerra Gold Inc1 University Avenue, Suite 1800TORONTO M5J 2P1CanadaCAN
  • Phone+1 (416) 204-1953
  • Fax+1 (416) 204-1954
  • Websitehttps://www.centerragold.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.